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The study of the development of B cells in the various lymphoid tissues in vivo is 
complicated by factors relating to cell  migration.  An in  vitro organ culture system 
provides an opportunity for analyzing the differentiation of B lymphocytes in a closed 
system without the complication of cell migration. Moreover, it is possible to manip- 
ulate the experimental conditions in vitro in an attempt to alter the development of 
B cells and learn more about the process. One such manipulation is the addition of a 
tolerogen (e.g.,  a hapten protein conjugate) to the culture medium to study its effect 
on the development of hapten specific B cells. 
It has previously been shown that  some in  vitro systems can support  the growth 
and differentiation of fetal lymphoid tissues.  Melchers et al.  (1)  have demonstrated 
that single-cell suspensions of fetal liver cells  will develop mitogen-reactive B cells in 
culture. Owen et al. (2, 3) have also presented evidence for maturation of B cells with 
fetal liver or fetal spleen organ cultures.  Explants of fetal tissue taken before the in 
vivo appearance of B lymphocytes that bear surface immunoglobulin (s-Ig)1 generated 
s-Ig-positive B cells in culture. In addition, as early as 11-12 d of gestation a putative 
precursor of the s-Ig-positive cell, termed a  pre-B cell, was identified by immunoflu- 
orescence techniques and shown to contain cytoplasmic IgM but to lack functional s- 
Ig receptors (1, 3-5). Other investigators have demonstrated the maturation of B cells 
in  fetal  tissues  by measuring the development of antigen-binding cells  (6-8).  Thus, 
the majority of studies with fetal tissues, particularly in vitro studies, have followed B- 
cell  differentiation  by  the  acquisition  of mitogen  reactivity,  the  development  of 
antigen  binding cells,  or the acquisition  of s-Ig. Although these markers do indeed 
reflect the maturation of B cells, they do not address the most important aspect of the 
B cell,  namely the production of antibody to a specific antigen. 
In the past it has been very difficult to study the specific responses of fetal lymphoid 
cells  or  even  neonatal  cells  because  of the  small  number  of B  cells  present  for  a 
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particular antigen and the lack of functionally mature cooperating cells, e.g., macro- 
phages  and  T  cells  (9).  This  constraint  has  recently been  removed  through  B-cell 
cloning assays, in particular, the in vitro splenic focus assay developed by Klinman 
and Press (10,  11)  in which the adult splenic environment  is provided complete with 
carrier-primed T  cells, thus facilitating the measurement  of B-cell precursors in fetal 
and  neonatal  tissues.  It  is, therefore,  of great  interest  to  combine  the  technique  of 
organ culture with this sensitive B-cell cloning assay to study the differentiation of B 
cells in relation to immune reactivity. 
In  this  paper  we  compare  the  normal  in  vivo  development  of B-cell precursors 
specific for the hapten determinant 2,4-dinitrophenol (DNP) with the development of 
DNP  precursors  that  occurs  in  the organ  culture  system.  The  results  indicate that 
both  fetal spleen and fetal liver contain lymphocyte progenitor cells that will differ- 
entiate into B cells as measured by the acquisition of clonable DNP precursors as well 
as by the acquisition of s-Ig-positive cells. 
Evidence is presented for both a  quantitative difference in the frequency of DNP 
precursors before and after culturing, and for a  qualitative difference in that some of 
the B-cell precursors that mature in vitro acquire the ability to make antibody of the 
IgG isotypes. Finally, the effect of the presence of the DNP determinant  during the 
process of B-cell maturation was studied,  the result  being near total elimination of 
potential anti-DNP clones. 
Materials  and  Methods 
Animals and Immunizations.  The  animals used in these studies were specific pathogen-free 
(SPF), inbred CBA/CaH/WEHI mice that were bred and maintained at The Walter and Eliza 
Hall Institute of Medical Research (Victoria, Australia). Spleens and livers were obtained from 
fetuses of dated gestational age ranging from  12 to 19 d. The age of gestation was determined 
by vaginal plugging; day 0 of gestation being the day that a vaginal plug was detected. 
SPF  female  mice  of 6-8  wk  of age  were  injected  with  0.1  mg  i.p.  of keyhole  limpet 
hemocyanin (KLH) in complete Freund's adjuvant. These mice were used in the splenic focus 
assay as recipients for transferred cells 6-8 wk later. 
Hapten-Protein Conjugates.  DNP  was  conjugated  to  KLH,  bovine serum  albumin  (BSA), 
ovalbumin (OVA), or human gamma globulin (HGG) as previously described (12). DNP-KLH 
contained -10 mol DNP/100,000  daltons of KLH.  DNP-BSA, DNP-OVA, and DNP-HGG 
contained ~ 10 mol DNP/mol protein. The hapten 4-hydroxy-3-iodo-5-nitrophenylacetic  acid 
(NIP) was conjugated to HGG according to standard procedures (13) and contained  10 mol 
NIP/mol protein. 
Organ Culture Technique and Tolerance Induction.  Spleens and livers were dissected from fetuses 
and placed in organ culture in a manner similar to that previously described for fetal thymus 
lobes (14). Briefly, intact fetal spleen or small pieces of fetal liver were placed on the surface of 
strips of sterile Millipore filter (Millipore Corp., Bedford, Mass.) that rested on surgical gelatin 
rafts (Gelfoam, The Upjohn Co. Kalamazoo, Mich.) immersed in Dulbecco's modified Eagle's 
medium (DMEM) that contained 15% fetal calf serum. The level of medium was adjusted such 
that the Millipore filters were at the gas/medium interface and the tissue was in the gas phase. 
The fetal tissues were incubated for various times in 10% C02 and 90% air, and the medium 
was changed every 3rd d. At the end of 3-9 d  in culture the fetal tissue was dispersed into 
single-cell suspensions, and an aliquot was removed for counting and determining the percent- 
age ofs-Ig-positive  cells by direct immunofluorescence with a fluorescein isothiocynate (FITC)- 
conjugated, polyvalent, rabbit anti-mouse immunoglobulin (14). The cultured cells were then 
tested for the number of DNP-specific B-cell precursors in the in vitro splenic focus assay. 
Tolerance induction was studied by incubating the organ cultures in DMEM that contained 
the  tolerogen DNP-OVA or DNP-HGG  at  5  X  10 -7 M  DNP,  for the  duration  of culture. 
Similar results were obtained when either carrier was used. j.  M.  TEALE AND T.  E.  MANDEL  431 
Cell Transfers, Splenic Focus Assay, and Tolerance Induction.  Mice that  had been primed with 
KLH were given 1,300 rad of total body irradiation 4-6 h before cell transfer. Each irradiated, 
carrier-primed recipient received 2-20 X  l0  s viable, nucleated cells from organ cultures or from 
uncultured fetal spleens or livers that were dispersed into single-cell suspensions. The recipients 
were sacrificed ~ 14-16 h later, and the number of DNP-specific precursors was determined in 
an in vitro splenic focus assay (10,  1.1). 
The degree of tolerance susceptibility of cultured fetal B  lymphocytes was determined by 
inducing tolerance in the organ cultures as described above. The susceptibility of uncultured B 
lymphocytes to tolerance induction, on the other hand, was determined by a  modification of 
the splenic focus assay outlined by Metcalf and  Klinman  (15).  In short,  fragment  cultures 
derived  from  recipient spleens were  incubated  for  24  h  in  high  glucose DMEM  plus  10% 
agamma horse serum with or without the presence of the tolerogen DNP-HGG or DNP-OVA 
at 5 ×  10  -7 M  hapten. No significant difference was found in the degree of tolerance obtained 
with either DNP-HGG or DNP-OVA. 
The tolerogen was washed out  24 h  later, and  DMEM  that contained the antigen DNP- 
KLH (5 ×  10  -7 M  DNP) was added. Culture supernates were subsequently replaced on day 4 
and changed every 2-3 d  thereafter. Supernates were collected at approximately day  12 and 
analyzed for the presence of anti-DNP by radioimmunoassay. 
Radioimmunoassay and lsotype Analysis.  Culture supernates (20-50/11)  collected on day 12 after 
stimulation were then assayed for anti-DNP antibody. The immunoglobulin was detected by 
a solid phase radioimmunoassay (16) through the use of a mixture of purified 125I-labeled sheep 
anti-mouse Fab and purified x25I-labeled rabbit anti-X (17). Those supernates that were positive 
for anti-DNP were reanalyzed for the isotype(s) present. This was accomplished with the same 
radioimmunoassay except that  the  following purified 125I-labeled,  rabbit anti-mouse heavy- 
chain-specific antibodies were used:  (a) anti-IgM, (b) anti-IgG1, (c) anti-IgA, (d) anti-IgG2a, 
(e) anti-IgG2b, and (J0  anti-IgG3. The radioimmunoassay as well as the purification of class- 
specific reagents have been described in detail (17). 
Results 
Acquisition  of s-Ig-Positive  Cells  in  Fetal Lymphoid  Tissues  In  Vivo and In  Vitro.  The 
normal  maturation  of  B  lymphocytes  during  fetal  development  was  studied  by 
analyzing the percentage of s-Ig-positive lymphocytes in liver and spleen suspensions 
obtained  at  various  stages  of gestation.  The  percentage  of s-Ig-positive cells  was 
determined by fluorescence microscopy with  a  FITC-conjugated, polyvalent, rabbit 
anti-mouse immunoglobulin  (14),  and  -500-1,000  cells were counted  for each  esti- 
mate. The results are presented in Fig. 1. Day 17 is the first day in which s-Ig-positive 
cells  are  reproducibly  detected  in  both  spleen  and  liver,  and  approximately 
the same percentage of si-Ig-positive cells are found in both tissues at this age. At day 
18, however, there is a  greater percentage of s-Ig-positive cells in the spleen compared 
with the liver; this difference'is even greater at days 19 and 20. The greatest increase 
in the percentage of s-Ig-positive cells in both spleen and liver occurs between days 18 
and  19 of gestation when there is a  greater than fivefold increase in s-Ig-positive cells. 
The development of fetal B lymphocytes was also studied in vitro with an improved 
organ culture technique (14). Spleens and livers were removed from fetuses at various 
ages of gestation and incubated in organ culture for varying periods of time. At the 
end of the culture period the tissues were dispersed into single-cell suspensions and an 
aliquot of cells was tested for the percentage of s-Ig-positive lymphocytes by fluores- 
cence microscopy (Tables I and II). 
The data in Table I demonstrate that organ cultures of spleen support the in vitro 
development of s-Ig-positive lymphocytes. Spleens taken at  17  and  18  d  of gestation 
showed the greatest  increase in s-Ig-positive cells after 3  d  in culture  (10- to  12-fold 432  DIFFERENTIATION OF FETAL B LYMPHOCYTES 
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Fro.  1.  The percentage of s-Ig-positive cells  found in spleens (O) and livers  (O) at various ages of 
gestation. Spleens and livers were removed from fetuses at various gestational ages, dispersed into 
single-cell  suspensions, and examined for the percentage of s-Ig-positive cells by direct immunoflu- 
orescence with FITC-anti-mouse Ig. Each point represents the mean of 2-7 experiments. Error bars, 
which represent the standard error of the mean, are shown where three or more experiments were 
done. 
increase).  Cultures  of fetal  spleen  explants  taken  at  15  d  of gestation,  on the other 
hand, produced variable results, and most cultures resulted in no maturation of s-Ig- 
positive cells. 
The development  of soIg-positive lymphocytes in  these  cultures  is  not  a  result  of 
selective survival but rather to a  net increase in the number of s-Ig-positive cells. For 
example,  there  are  ~106  nucleated  cells  in  a  17-d  fetal  spleen,  and  after  3-5  d  in 
culture  4-6  ×  105 cells per spleen  are  recovered, or about  one-half the original  cell 
number.  As  a  maximum  this  could  account  for  a  two-fold  increase  in  B  cells  by 
selective survival. However, because there is an ~ 10-fold increase in s-Ig-positive cells 
during the culture period there must be a  net increase in the number of s-Ig-positive 
cells.  It  is  not  clear  whether  this  increase  is  a  result  of differentiation  of existing 
progenitor cells or if cell proliferation also occurs. However, in histological sections of 
cultured fetal tissues many mitotic figures can be identified  (data not show). 
Cultures  of fetal  liver explants  also support  the development  of s-Ig-positive cells 
(Table II). Liver explants taken at  14 and  15 d of gestation  (before the appearance of 
s-Ig-positive cells)  contain  1.5-2% s-Ig-positive ceils after 3-5 d  in culture,  and liver 
explants  taken  at  17  and  18  d  of gestation  show  a  five- to sixfold  increase  in  s-Ig- 
positive cells after 3-7 d  in culture. J.  M.  TEALE  AND  T.  E.  MANDEL 
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Age of fe-  Number  Percentage of s-  Dura-  Number 
tal spleen  of exper-  Ig-positive cells  tion of  of exper- 
precuhure  iments  precuhure  culture  iments 
Percentage of s-Ig-positive cells 
postcuhure 
DNP-treated cul-  Control culture  ture 
d  d 
15  6  0 ±  0  5  3  0.3 ±  0.3  0.8 ±  0.2 
17  6  0.6 ±  0.2  3  5  7.9 ±  0.7  5.3 ±  0.6 
7  2  3.0  3.8 
18  4  1.0 ±  0.3  3  3  12.5 ±  4.8  9.4 4- 3.8 
19  7  5.3 ::t: 0.8  5  2  7.0  9,4 
7  2  5.2  6.2 
* Spleens were removed from CBA/H fetuses at the indicated ages of gestation and a small proportion of 
the spleens were dispersed into single-cell suspensions and analyzed for the percentage s-Ig-positive cells 
by direct  immunofluorescence with  FITC-anti-Ig.  The  remainder of the spleens were  used  intact  as 
explants and incubated in organ culture in the presence or absence of DNP-HGG or DNP-OVA (5 × 
10  -7 M  DNP) for the specified periods of time. After incubation, the explants were dispersed into single- 
cell suspensions, and an aliquot was tested for the percentage of s-Ig-positive cells. Between 500 and 1,000 
cells were counted for each estimate. The data are expressed as the mean +  SE of the indicated number 
of experiments. 
TABLE  II 
Maturation of s-lg-Positive Lymphocytes  In  Vitro -  Fetal Liver* 
Age of fe-  Number  Percentage of s-  Duration of  Number 
tal liver  of exper-  Ig-positive ceils  culture  of exper- 
precuhure  iments  precuhure  iments 
Percentage of s-Ig-positive cells 
postcuhure 
DNP-treated  Control culture  culture 
d 
12 
14 
15 
17 
18 
19 
d 
3  0 ±  0  ND~ 
7  0±0  3  3  1.7±0.8  2.0±  1.0 
5  1  0.8  1.5 
8  0+0  5  5  1.4--.0.1  1.9±0.5 
6  0.4 ±  0.2  3  5  1.4 ±  0.4  2.2 4- 0.5 
7  1  1,8  2_0 
3  0.3 ±  0.1  3  2  2.5  2.0 
5  1.8 ±  0.4  5  3  2.4 ±  0.6  1.9 ±  0.3 
7  2  1.0  1.7 
* Fetal livers were analyzed in the same manner as described in Table I. Data are expressed as the mean 
±  SE of the indicated number of experiments. 
Not done. 
Because  it was  planned  to study  the  tolerance  susceptibility  of these developing  B 
lymphocytes  in organ  culture  to the DNP  determinant,  it was important  to determine 
if the  tolerogens  DNP-HGG  or DNP-OVA  (5  ×  10 -7 M  DNP)  affected  the develop- 
ment  ofs-Ig-positive  cells. The  data  in Tables  I and  II demonstrate  that the incubation 
of either  fetal spleen  or liver explants  in the  presence  of the  DNP  protein  conjugates 
does not  alter the percentage  of s-Ig-positive cells obtained. 
Determining  the Optimal Length  of Incubation  Time for Organ  Cultures.  It  was  necessary 
to  determine  if there  was  an  optimal  length  of time  for culturing  the  explant  tissues 
so as to obtain  maximum  numbers  of newly  developed  B  lymphocytes.  Consequently, 434  DIFFERENTIATION  OF  FETAL  B  LYMPHOCYTES 
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FIG.  2.  The effect  of varying length of incubation  time on  the percentage of s-Ig-positive cells 
obtained after organ culture. Fetal spleen  (1~-------O) and liver (0---0)  were removed at  17 d  of 
gestation and  incubated in organ culture for various periods of time. After incubation, the fetal 
tissues were dispersed into single-cell suspensions and tested for the percentage of s-Ig-positive cells 
with FITC-anti-mouse Ig. 
spleens and livers were removed from fetuses at  17 d of gestation and placed in organ 
cultures  for varying periods of time.  The results,  presented  in  Fig.  2,  indicate  that 
there is an increase in the percentage of s-Ig-positive cells with time in culture with a 
peak occurring between 3 and 5 d. After ~5 d in culture, however, there is a decrease 
in  the  percentage  of  s-Ig-positive  cells.  Consequently,  fetal  organ  cultures  were 
incubated for 3-5 d unless specified otherwise. 
Acquisition of B-Lymphocyte Function during Normal Fetal Development: Degree of Tolerance 
Susceptibility.  So that  the normal  development of B-lymphocyte function  could  be 
studied, populations of spleen and liver cells of various ages of gestation were tested 
for the frequency of clonable DNP precursors by using a splenic focus assay (10,  1 l). 
The  frequency  of clonable  DNP  precursors  in  spleen  increases  as  a  function  of 
gestational age (Fig. 3, open bars). Few, if any, DNP precursors are detectable in  15- 
d  fetal  spleens,  but  thereafter  the  frequency  of  DNP  clones  detectable  steadily 
increases at  17,  18, and  19 d of gestation, respectively. The ontogenetic development 
of B-lymphocyte function in fetal liver was also studied (Fig. 4, open bars). Similar to 
fetal spleen there is an increase izl the frequency of DNP precursors with increasing 
age of gestation.  B-cell precursors specific for DNP were not detectable until day  14 
of gestation, and by day 19 the frequency had increased by more than threefold. 
The percentage of fetal B-cell precursors that were susceptible to tolerance induction 
was determined  by a  modification  of the splenic  focus assay  (15)  in  which  spleen J.  M.  TEALE  AND  T.  E.  MANDEL  435 
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FIG.  3.  Acquisition of clonable  DNP-specific precursors during normal fetal development-fetal 
spleen. Spleens were removed at the gestational ages indicated, dispersed into single-cell suspensions, 
and  transferred  to  lethally  irradiated,  carrier-primed  recipients  for  analysis in  the splenic  focus 
assay.  About  2-15  ×  106  cells  were  injected  per  recipient,  3-4  mice  per  experimental  group. 
Fragment cultures were incubated  in the presence or absence of DNP-HGG or DNP-OVA  (5 X 
7  7  10-  M  DNP) for 24 h followed by 3-d stimulation with DNP-KLH (5 ×  10-  M  DNP). Supernates 
were collected at day  12, and anti-DNP-secreting clones were detected by radioimmunoassay with 
125I-labeled  anti-Fab. The data are expressed as the mean frequency of DNP clones detected from 
2-7 experiments, and error bars are shown where three or more experiments were done. I-1, frequency 
obtained with control fragment cultures; ml, frequency obtained with DNP-HGG- or DNP-OVA- 
treated  fragment cultures; [],  frequency obtained  in tolerance specifcity control where fragment 
cultures were treated for 24 h with NIP-HGG followed by 3-d stimulation with DNP-KLH. 
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FI6.  4.  Acquisition of clonable  DNP-specific precursors during normal fetal development-fetal 
liver. Fetal livers were analyzed in the same manner as described in Fig. 3. 
fragments were incubated with the tolerogen DNP-HGG  or DNP-OVA  (5  ×  10 -7  M 
DNP)  for the  1st  24  h  of culture.  The tolerogen was then washed out,  the antigen 
(DNP-KLH, 5 ×  10  -7 M  DNP) added, and the assay continued as usual to determine 
the resulting frequency of DNP clones. By use of this tolerance protocol, -65-70%  of 436  DIFFERENTIATION  OF  FETAL B  LYMPHOCYTES 
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FIG.  5.  Acquisition ofclonable DNP-specific precursors in vitro- fetal spleen. Spleens were removed 
at the gestational ages specifed and incubated in organ culture in the presence or absence of DNP- 
HGG  or DNP-OVA  (5 ×  10  -7 M  DNP)  for 3-5 d. The explants were then dispersed into single-cell 
suspensions and  transferred into  lethally irradiated, carrier-primed recipients for analysis in  the 
unmodified splenic focus assay. About  2-7  ×  10  6 cells were injected  per  recipient,  3-4 miceper 
experimental group. Fragment cultures were incubated in the presence of DNP-KLH  (5 ×  10-' M 
DNP)  for 3-4 d. Supernates were collected at day  12, and anti-DNP-secreting clones were detected 
by radioimmunoassay  with 1251dabeled anti-Fab. The data are expressed as the mean frequency of 
2-7 experiments, and error bars are shown where three or more experiments were done. I-I, frequency 
obtained with control organ cultures; ", frequency obtained with DNP-HGG  or DNP-OVA  (5 × 
10  -7 M); ~  frequency obtained in tolerance specificity control where organ cultures were treated 
with NIP-HGG  (5 X  10  -7 M). 
the potential  DNP clones  are eliminated  when spleen  cells  are taken at  17 and  18 d 
of gestation, and >80% are eliminated  at  19 d of gestation.  When liver cells are tested 
in  the  modified  splenic  focus  assay  for  tolerance  susceptibility,  ~50-60%  of  the 
potential  DNP clones  are eliminated  at  14,  15,  17, and  18 d  of gest~ition,  and ~80% 
are eliminated  at  19 d  of gestation. 
Acquisition of B-Lymphocyte Function during Fetal Development In  Vitro.--  Because  some 
of the explants  of fetal  lymphoid  tissue  showed  a  >10-fold  increase  in  s-Ig-positive 
cells,  we were particularly  interested  in analyzing the development  of B-lymphocyte 
function  in  these organ cultures.  Fig.  5  (open bars)  illustrates  the frequency of DNP 
precursors obtained  when  fetal  spleens taken at  15,  17,  18, and  19 d  of gestation  are 
incubated  in organ culture for 3-5  d. At all ages of gestation  tested,  the frequency of 
DNP precursors detected  is greater after 3-5 d  in organ culture as compared with the 
age-matched  uncultured  controls  (Fig.  3  vs.  Fig.  5).  However,  spleens  at  15  d  of 
gestation  that  contain  little or no B-cell  activity before organ culture rarely show an 
increase in B-cell  activity after 3-5  d  in organ culture. 
A similar analysis of various ages of fetal liver that were incubated in organ culture 
for 3-5 d is presented in Fig. 6. Although the data are not conclusive for all gestational 
ages  tested,  culturing  fetal  liver  in  vitro  for 3-5  d  results  in an  increase  in  clonable j.  M.  TEALE  AND  T.  E.  MANDEL 
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FIo.  6.  Acquisition of clonable DNP-specific precursors in vitro-fetal liver.  Livers were analyzed 
in the same manner as described in Fig. 5. 
DNP precursors compared with the age-matched uncultured controls  (Fig. 4 vs. Fig. 
6). As with the spleen cultures, the increase in B-cell activity is more apparent at the 
earlier ages of gestation tested. 
Effect  of  Tolerogen on  the  Acquisition  of B-Cell  Function during Fetal  Development In 
Vitro.  To determine if the differentiation of DNP precursors occurring in vitro could 
be influenced by environmental factors, fetal spleen and liver explants were incubated 
in organ cultures in the presence or absence of tolerogen (DNP-HGG or DNP-OVA). 
It should be noted that  the tolerance protocol used in the organ cultures  is distinct 
from that used in the modified splenic focus assay that was used to study tolerance 
induction  in  uncultured  fetal spleen  and liver as described above. After incubating 
fetal tissues in organ culture in the presence of tolerogen for 3-5 d, the cultured tissues 
are then  dispersed  into single-cell suspensions and  tested  in  the unmodified  splenic 
focus assay for the frequency of DNP precursors. 
The effect of the presence of the DNP determinant in the spleen organ cultures on 
the  developing  DNP-specific  B-cell  precursors  is  shown  in  Fig.  5.  At  all  ages  of 
gestation tested there is a reduction of ~80% in the frequency of DNP clones, although 
the day-15 result is not an accurate one because of the lack of a reproducible increase 
in  the  frequency  of DNP  precursors  after culturing  in  vitro  as  mentioned  above. 
Likewise, the incubation of fetal liver explants of various ages in the presence of DNP- 
HGG or DNP-OVA results in nearly total abrogation of potential DNP clones with 
usually an 80-90% reduction  (Fig. 6). 
The degree of tolerance obtained as a  result of incubating spleen and liver organ 
cultures with the hapten for 3-5 d  is consistently greater than the degree of tolerance 
obtained  with  uncultured  fetal lymphoid cells as measured  in  the modified splenic 
focus assay in which the tolerogen is present for 24 h. Perhaps this difference is related 
to the length of time that the fetal lymphocytes are exposed to tolerogen. 
Analysis of the Isotypes Secreted by DNP Clones  from Both Cultured and Uncultured Fetal B 
Cells.  DNP clones  that  were detected  by radioimmunoassay with  an  ~25I-anti-Fab 438  DIFFERENTIATION OF FETAL B LYMPHOCYTES 
TABLE III 
Isotypes Secreted by DNP Clones from Fetal Spleen * 
Number of 
Age of fetal  clones ana- 
spleen  lyzed 
Isotype distribution::~ Percentage of clones expressing 
lgM  IgM + IgA  IgA  IgM + IgG§  IgGll 
d 
Uncultured 
17  10  60.0  30.0  10.0  0  0 
18  34  52.9  26.4  14.7  5.9  0 
19  18  50.0  11.1  11.1  5.5  22.2 
Cultured¶ 
17  44  50.0  18.2  13.6  11.3  6.8 
18  10  60.0  10.0  10.0  0  20.0 
19  20  60.0  10.0  10.0  10.0  20.0 
*  DNP-specifie clones that resulted from the antigenic stimulation of both uncultured  and cultured fetal 
spleen cells were detected in radioimmunoassay by 125I-labeled  anti-Fab. The DNP-specific clones were 
then reanalyzed for isotype distribution  with the following t25I-labeled  purified anti-heavy-chain  anti- 
bodies: anti-IgM, anti-lgG1, anti-lgG2a, anti-IgG2b, anti-lgG3, and anti-IgA. 
:~ Results expressed as the percentage of clones secreting the isotypes specified. Because the number of 
clones analyzed and the complexity of the data IgG1, IgG2a, IgG2b, and IgG3 were grouped as IgG. 
§ This grouping includes those clones positive for IgA + IgM + IgG. 
II This grouping includes those clones positive for IgA + IgG. 
¶  Age of fetal spleen before culturing for 3-5 d. 
were reanalyzed for the isotypes being secreted by repeating the radioimmunoassay 
with  the  following lzSI-labeted anti-class-specific antibodies:  (a)  anti-IgM,  (b)  anti- 
IgG1,  (c) anti-IgA, (d) anti-IgG2a, (e) anti-IgG2b, and  (f)  anti-IgG3. Because of the 
complexity of the data and the number of clones analyzed, however, the IgG classes 
were grouped together. 
Table III presents the distribution of isotypes secreted by clones produced by both 
uncultured  fetal spleen lymphocytes and those that had been incubated as explants 
in organ culture. The data suggest that uncultured  spleen cells taken at  17 and  18 d 
of gestation rarely result in clones that secrete IgG classes (IgM plus IgG or IgG) even 
in  the  presence of adult T-cell help.  By  19  d  of gestation, on  the other  hand,  the 
ability to produce IgG is more pronounced. If, however, the spleens at  17 and  18 d  of 
gestation are incubated in organ cultures for 3-5 d  before analysis in the splenic focus 
assay, the B  ceils appear to mature in vitro and acquire the ability to produce IgG. 
The  analogous experiments  with  fetal  liver as the source of potential  B  cells are 
presented  in  Table  IV.  Consistent  with  the  results  obtained  with  fetal  spleen,  the 
proportion of uncultured  liver cells that  are able to produce IgG  (IgM plus IgG or 
IgG) appears to increase with the age of gestation. Also consistent with the fetal spleen 
results is the finding that  this maturation occurs in vitro because fetal liver explants 
incubated in  organ  culture  before  analysis  for  DNP  precursors  result  in  a  greater 
proportion of clones that secrete the IgG classes. 
Interestingly, both fetal spleen and fetal liver B-cell precursors, regardless of whether 
or not they are incubated  first in organ culture, produce a  substantial proportion of 
clones  that  secrete  IgA  (IgM  (IgM  plus  IgA  or  IgA).  In  fact,  with  the  possible 
exception of uncultured  15-d fetal spleen, a  temporal difference in the ability of fetal 
B  cells  to  produce  IgM  vs.  IgA  could  not  be  detected  under  the  experimental 
conditions used, although  the predominant  isotype distribution in all cases was IgM J.  M.  TEALE AND T.  E.  MANDEL 
TABLE IV 
Isotypes Secreted by DNP Clones  from Fetal Liver* 
439 
Number of 
Age of fetal  clones ana- 
liver  lyzed 
Isotype distribution: Percentage of clones expressing 
IgM  IgM + IgA  IgA  IgM + IgG  IgG 
d 
Uncultured 
14  56  51.8  28.6  16.l  1.8  1.8 
15  10  70.0  20.0  10.0  0  0 
17  35  51.4  45.7  0  2.8  0 
18  32  56.2  40.6  3.1  0  0 
19  24  62.5  4.2  25.0  4.2  4.2 
Cultured 
14  37  62.2  21.6  8.1  5.4  2.7 
15  15  53.3  20.0  13.3  6.7  6.7 
17  19  73.7  10.5  0  10.5  5.3 
18  10  60.0  10.0  10.0  10.0  10.0 
19  20  60.0  10.0  10.0  10.0  10.0 
* See Table III footnotes. 
only. All of the DNP clones analyzed from  15-d uncultured fetal spleen secreted IgM 
only, but this result  represents  the analysis of only a  few clones because of the small 
numbers of lymphoid cells present in 15-d fetal spleen and the low frequency of DNP- 
specific precursors. 
Discussion 
This  study  was  undertaken  to  examine  the  maturation  of B-cell  function  and 
tolerance  susceptibility  during  fetal  development  at  the  level  of individual  B  cells. 
Differentiation was assessed by determining the frequency of clonable DNP precursors 
with an in vitro splenic focus assay (10,  11) that had been previously shown to detect 
a  range of B-cell subpopulations  including immature tolerance-susceptible  subpopu- 
lations (17-19). In addition, recent evidence indicates that the splenic focus assay can 
detect a  subset  of s-Ig-negative cells of the B-cell lineage, possibly pre-B cells, which 
is a  further indication that this cloning assay is suitable for studies of B-cell develop- 
ment  (20). 
The  antigen  DNP  was chosen  for these  studies  because  Klinman  and  Press  (21) 
have previously demonstrated that there are at least  three major neonatal anti-DNP 
specificities  or  clonotypes  that  are  expressed  in  high  numbers  during  neonatal 
development. This is in contrast to specificities directed against other haptens such as 
phosphorylcholine, which develop later in ontogeny (22). From these results Klinman 
and Press  (21)  predicted that the DNP clonotypes would be expressed as early as the 
15th d  of gestation in fetal spleen. Therefore, DNP appeared to be a suitable antigen 
for studies of B-cell function during fetal development. 
B-cell differentiation  can first be detected  in fetal  liver and fetal blood at the  11- 
12th d  of gestation with  the appearance  of cells able to synthesize cytoplasmic IgM 
(1, 3, 4, 23). The acquisition of s-Ig-positive cells  (3, 8)  and antigen-binding cells  (6- 
8)  first occurs at  15-17 d  of fetal  life.  In these studies of CBA/H  mice it was shown 
that day 17 of gestation was the 1st d in which s-Ig-positive cells could be reproducibly 
detected by immunofluorescence in both  fetal spleen  and liver.  However, by day  14 440  DIFFERENTIATION OF  FETAL B LYMPHOCYTES 
of  gestation,  before  the  appearance  of s-Ig-positive cells,  there  was  a  small  but 
detectable  frequency  of  DNP-specific  precursors  in  fetal  liver.  This  result  lends 
credence to the suggestion that the splenic focus assay may support  the maturation 
and subsequent cloning of a subset of pre-B cells (17,  20). After 15 or 16 d of gestation 
there is a  gradual increase in the percentage of s-Ig-positive cells in spleen and liver 
with time of gestation, there being a marked increase occurring between  18 and  19 d. 
An analysis of the frequency of DNP-specific precursors also shows an increase in B- 
cell activity with time of gestation but there is no sudden increase of DNP precursors 
between  18 and  19 d of gestation that would correlate with the marked increase in s- 
Ig-positive cells. Perhaps this lack of correlation is a  reflection of the contribution  to 
the DNP precursor frequency made by s°Ig-negative B-cell progenitors. The spleen of 
the adoptive host appears to provide a suitable environment such that DNP progen- 
itors mature and  acquire  receptors  during  the  first  few  days of the  assay and  can 
subsequently be stimulated with T-cell help  (20).  This finding is reminiscent of the 
studies of Sherr et al. (24, 25) who found that fetal and neonatal B cells, if anything, 
mature faster in adult  irradiated  hosts than in the intact donor.  Maturation,  in this 
case, was assessed in  terms of the ability to produce a  heterogeneous response with 
respect to antibody affinity. 
Another factor that could contribute to the lack of correlation between s-Ig-positive 
cells and precursor frequency around the time of birth relates to the mechanism by 
which diversification of B-cell specificities may occur. Considerable evidence indicates 
that there is a sequential appearance of various specificities or clonotypes (22, 26,  27), 
and  day  18  or  19  may mark the  appearance  of many later-developing,  non-DNP 
specificities. 
In light of recent  suggestions that  the T-independent  response develops first and 
that the precursor for the T-dependent response is the more mature B cell that bears 
both IgM and IgD receptors (28), it is interesting that a T-dependent response can be 
obtained  from  14-d  fetal liver,  5-7  d  before the  in  vivo appearance of s-IgD. This 
finding tends to argue against the requirement  for a  more mature B cell as does the 
study  in  which  T-dependent  responsive B  cells were  detected  from a  s-Ig-negative 
subset even in the presence of anti-IgD (29). 
The  ability  to  study  the  differentiation  of B  cells  in  an  organ  culture,  a  closed 
system, allows for the direct examination of B-cell progenitors that are present in the 
fetal spleen or liver before organ culture. This removes the complication of the influx 
of progenitors that  may be at earlier stages of development as well as the efflux of 
possibly more-mature cells. 
Culturing spleen and liver of various gestational ages as explants for 3-5 d  usually 
results in substantial  increases in the percentage of s-Ig-positive cells, a  finding that 
cannot  be explained  solely on  the  basis  of selective survival.  Because  some of the 
explants  were  taken  very early  in  gestation,  before the  appearance of s-Ig-positive 
cells, the results suggest that both fetal spleen and liver contain precursors that can 
differentiate into B lymphocytes. This is consistent with the results and conclusions of 
Owen et al. (2, 3)  and Bruyns et al. (8). 
By combining the techniques of organ culture and splenic focus assay the functional 
capacity of these developing lymphocytes was ascertained by measuring the frequency 
of DNP-specific B-cell precursors. It was determined that culturing explants of 14- to 
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the frequency of clonable DNP precursors as compared with age-matched uncultured 
controls.  However, the increases observed are greater at the earlier ages (i.e.,  14- to 
15-d  fetal  liver,  17-d  fetal  spleen),  which  suggests  that  the  progenitors  that  are 
eventually capable of producing DNP clones are present at the early stages of gestation 
but require time to expand and mature before they can be detected functionally. In 
addition,  with  the  exception  of  15-d  fetal  spleen,  it  appears  that  the  potential 
frequency of DNP clones after organ culture does not change with the gestational age 
of the tissue before organ culture. Thus, liver cultured at  14 d of gestation could give 
rise after 3-5 d  to the same frequency of DNP clones as fetal liver cultured at  18 d of 
gestation for 3-5 d, again suggesting that the progenitors for the early-appearing DNP 
specificities  are  present  as  early  as  14  d  of gestation  and  that  the  expansion  and 
maturation of these already-existing clonotypes can occur in vivo or in vitro resulting 
in an increased frequency of DNP clones. 
An observed increase in B-cell activity after culturing  15-d fetal spleen,  however, 
was variable. Perhaps at  15 d of gestation B-cell progenitors are just beginning to seed 
to  the  spleen  and  explants  removed at  this  critical  time may or  may not  contain 
progenitors  that  will  give rise  to  DNP-specific precursors.  Alternatively,  15-d  fetal 
spleen  simply may not  have the  requisite  microenvironment  for the  maturation  of 
progenitors of the B-cell lineage. 
A  further demonstration of the in vitro differentiation of B-cell progenitors during 
organ culture,  in  addition  to  the  rise  in  the  frequency of clonable  DNP-specific B 
cells,  was  the  increased  proportion  of clones  that  secreted  IgG classes  after organ 
culture.  Thus, uncultured  spleen and liver B-cell precursors gave rise to few, if any, 
DNP clones until  18 or  19 d  of gestation.  However, spleens or livers removed before 
19  d  of gestation  and  incubated  in  organ culture  gave rise to a  proportion  of IgG- 
secreting clones greater than the age-matched uncultured controls. Because the same 
adult T-cell help is provided for both uncultured and cultured fetal cell populations, 
there must be an intrinsic difference in the B-cell precursor after in vitro maturation. 
Other investigators have provided evidence for the ontogenetic expression of isotypes 
both with regard to s-Ig (30)  and to immunoglobulin secreted by stimulated cultures 
(31). 
However, once  this  maturation  with  regard  to  isotype has  taken  place  it  would 
appear from the results herein as well as from the results obtained with adult B cells 
(J.  M. Teale and H. Bathard.  Manuscript  in preparation.)  that many of the B ceils 
can give rise to clones that secrete several isotypes. This is inconsistent with the results 
of Lawton et al. (32), who concluded that B cells and their progeny are restricted with 
regard to the isotypes they or their progeny can express and that this restriction takes 
place early in the development of the B cell. On the other hand, there is considerable 
evidence  that  indicates  that  the  isotypes  secreted  by  antibody-forming  cells  are 
regulated  extensively by T  cells  and/or  T-cell  factors  (16,  33,  34).  Therefore,  the 
discrepancy may be partially explained by the effect of T  cells because Lawton et al. 
(32)  studied lipopolysaccharide-induced cultures. 
One particularly interesting aspect of the class analysis is the ability of immature 
fetal B cells to produce the IgA isotype with adult T-cell help. This is reminiscent of 
previous studies in which a subset ofs-Ig-negative cells from neonatal spleen contained 
clonable DNP precursors that  gave rise to a  considerable  proportion of clones  that 
secreted IgM plus IgA or IgA (20).  The ability of 14-d fetal lymphoid cells to produce 442  DIFFERENTIATION OF  FETAL  B  LYMPHOCYTES 
IgA-secreting clones is a further indication that lymphocytes capable of secreting IgA 
appear  earlier  in  ontogeny  than  has  previously  been  recognized  and  before  the 
appearance ofs-IgA (32). The ability to stimulate IgA production so early in ontogeny 
is probably related to the presence of adult T-cell help in the assay system. Indeed, 
the  IgA  response  seems  to  be  dependent  upon  the  availability  of  T  cells  (35). 
Moreover, recent  investigations have provided evidence for the T-cell regulation  of 
IgA synthesis (36). 
Notably, there appeared to be an ontogenetic relationship with regard to the degree 
of tolerance observed. Thus,  uncultured  fetal spleen  and liver populations  taken at 
earlier ages of gestation resulted in a lower degree of tolerance after a 24-h incubation 
with tolerogen than spleens or livers taken at  19 d of gestation or 1 d after birth (50- 
65% tolerance vs. 80-90% tolerance, respectively) as if the cells were in a pretolerant 
phase. This is in accord with a report by Szewczuk and Siskind (37), who found  14-d 
fetal liver to be particularly resistant to tolerance induction. 
One possible explanation for the relative resistance to tolerance induction of B cells 
obtained at the earlier ages of gestation relates to the rate at which a  population of 
fetal B  cells acquires  functional  s-Ig receptors.  Perhaps a  24-h  incubation  period  is 
insufficient time to affect all of the potential DNP precursors from early fetal lymphoid 
tissues,  and  maturation  and subsequent  cloning can occur to a  considerable extent 
after the removal oftolerogen. Consistent with this explanation is the finding that the 
degree of tolerance observed is increased  to an 80-90%  level when spleens or livers 
from the  earlier  ages of gestation  are  incubated  in  organ  culture  for 3-5  d  in  the 
presence  of tolerogen.  Presumably,  most  of the  progenitors  that  can  acquire  s-Ig 
receptors  in  vitro have done  so within  the  incubation  period,  and  the  presence of 
tolerogen during this maturation phase almost totally eliminates the potential anti- 
DNP clones. This is consistent with our previous results in which immature B cells in 
the  absence  of T  cells  are  highly  susceptible  to  tolerance  induction  (18,  20)  and 
provides strong evidence in favor of the clonal abortion theory (38). 
Although it is difficult to compare directly the normal development of fetal B cells 
with  the development occurring in vitro because of the inability to account  for cell 
migration in the former and cell death in the latter, it would appear that the in vitro 
development is substantial.  Indeed, where comparisons can be made with  the data 
available (e.g., 17-d fetal spleen cultured for 3 d vs. 1-d-old neonatal spleen), the DNP 
precursor frequencies are similar.  Thus the organ culture  system seems suitable  for 
investigating B-cell differentiation, and it is planned to study this process further by 
examining individual clonotypes. 
Summary 
The maturation of B-lymphocyte function during fetal development was studied in 
vivo and in an in vitro organ culture system. The results indicated that the progenitors 
for 2,4-dinitrophenol  (DNP)-specific B cells are present as early as 14 d of gestation in 
liver and possibly as early as 15 d  in spleen. In addition,  it was found that the organ 
culture system supports the development ofB lymphocytes as measured by an increase 
in both the percentage of surface immunoglobulin-positive cells and the frequency of 
clonable DNP-specific B cells after culturing. 
The majority of anti-DNP-secreting clones resulting from the antigenic stimulation 
of fetal  B  cells  produced  only the  IgM  isotype, and  the  ability to secrete  the  IgG j.  M.  TEALE AND T,  E.  MANDEL  443 
isotypes increased as a function of gestational age. Because fetal DNP precursors from 
spleens  and  livers  that  had  been  incubated  in  organ  culture  resulted  in  a  greater 
proportion of clones secreting IgG compared with age-matched uncultured controls, 
it  was concluded that  the  maturation  with  regard  to the ability to secrete  IgG can 
occur in vitro. 
In studies relating to the ontogenetic development of tolerance susceptibility, it was 
found that up to one-half of the DNP-specific B-cell precursors from livers and spleens 
<18  or  19  d  of gestation  were  resistant  to  tolerogen  treatment  for  24  h  as  if in  a 
pretolerant  phase.  However, if tolerogen were present  for 3-5 d  during organ culture 
there was near total elimination of potential DNP clones. This finding suggested that 
the 24-h induction period was insufficient for affecting the DNP-specific precursors in 
livers and spleens from the earlier gestational ages, and that a proportion of precursors 
could subsequently  form DNP clones in the splenic focus assay after the removal of 
tolerogen. 
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